Havas Lynx Faze is launched

Havas Lynx has launched a clinical trial recruitment agency called Havas Lynx Faze to tackle the problem with patient recruitment for trial studies. Apparently only 20% of studies manage to recruit on time, so this newly formed agency will help clients design a better patient trial experience, ensuring that patients aren’t delayed from getting the medicines they need. It will be led by newly appointed Mark Evans, former innovation director at Langland, where he set up a dedicated clinical trial media team.
Mr Evans said: “The plan for Faze is to change the way our sector communicates with trial patients. It’s a sector that has been driven by the needs of sites and has missed the fact that patients are not only the main participant, they now also have more studies then ever competing for their attention. We want to work with clients to put the patient at the centre of the trial experience and to design recruitment and retention solutions that provide support every step of the way.”
David Hunt, CEO of Havas Lynx, said: “Faze is aiming to combine creativity and technology to create patient-focused solutions in a market dominated by off-the-shelf solutions that aren’t getting the results clients and patients need. We’re investing heavily in setting up a team that will really drive change for patients looking for clinical studies, and we are delighted to welcome Mark to the Havas family.”